ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol

July 25, 1997

“Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”

July 14, 1995

Clinical Trials Approved By NCI

March 26, 2004

CCOPs Extended One Year While Waiting Evaluation

May 17, 1985

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995